Raymond James Downgrades Intercept Pharmaceuticals (ICPT) to Market Perform, 'FDA Likely Going to Punt on OCA in NASH'
Tweet Send to a Friend
(Updated - May 17, 2023 3:25 PM EDT)
Raymond James analyst Steven Seedhouse downgraded Intercept Pharmaceuticals (NASDAQ: ICPT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Raymond James analyst Steven Seedhouse downgraded Intercept Pharmaceuticals (NASDAQ: ICPT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
